The medical technology company Micropos Medical reported lower revenue for the second quarter compared with the same period last year. Operating loss increased.Revenue fell to SEK 1.1 million (3.3).Operating profit was SEK -9.5 million (-4.2). Profit after tax was SEK -9.5 million (-4.3), and per share SEK -0.05 (-0.03). Cash and cash equivalents amounted to SEK 17.3 million (21.1). During the period, the company carried out a new share issue of SEK 24.5 million before issue costs.Micropos says that the second quarter was characterized by high activity and several important advances. The company has around 15 active customers and an additional number in the installation phase.So far, about 430 patients have been treated with support from the Raypilot System, and the ASBRT treatment method is clinically documented. The focus is now on getting both existing and new customers to use the system more routinely in patient treatments.Micropos Medical, MkrQ2-2026Q2-2025ChangeNet sales1.13.3-66.7%Operating profit-9.5-4.2Net profit-9.5-4.3Earnings per share, SEK-0.05-0.03Cash and cash equivalents17.321.1-18.0%